Yale Alzheimer Disease Research Center
耶鲁大学阿尔茨海默病研究中心
基本信息
- 批准号:9293193
- 负责人:
- 金额:$ 166.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-15 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAdvisory CommitteesAlzheimer&aposs DiseaseAmyloid beta-ProteinAutopsyAwardAxonBedsBiologicalBiological AssayBiological MarkersBiologyBlood CellsBrainCareer MobilityCellular biologyClinicClinicalClinical DataClinical TrialsCommunitiesConnecticutDNADataDementiaDevelopmentDiseaseEducation and OutreachEmotionalFacultyFailureFamilyFunctional disorderFundingFutureGeneticGeriatricsGoalsHospitalsImageImpaired cognitionKnowledgeLaboratoriesLaboratory ResearchLeadLifeLinkLysosomesMass Spectrum AnalysisMedical StudentsMemoryMemory DisordersMentorsMentorshipMethodologyMethodsMinorityMolecularMonitorMusNerve DegenerationNeurologyNeuronsNeuropsychologyNeurosciencesNursing FacultyOptical MethodsOrganellesPathologyPathway interactionsPeptidesPilot ProjectsPositron-Emission TomographyPresenile Alzheimer DementiaProteomicsRecording of previous eventsRecordsResearchResearch PersonnelResearch Project GrantsResourcesRoleSerumSignal TransductionSpecificitySpecimenSynapsesTestingTherapeuticTrainingTranslatingUnited States National Institutes of HealthVocational GuidanceWhole BloodWorkawakebrain tissuecareercareer developmentclinical carecohortdata managementdensityexome sequencingexperimental studygraduate studenthuman subjecthuman tissueinduced pluripotent stem cellmembermultiple reaction monitoringnetwork dysfunctionneuroimagingneuropathologyneuroproteomicsnoveloutreachproteostasispublic health relevancereceptorrepairedresearch and developmentresearch facilityresearch studysample collectionstatisticssuccess
项目摘要
DESCRIPTION (provided by applicant): The Yale ADRC seeks to advance our understanding of Alzheimer's disease with the eventual goal of translating laboratory discoveries into novel effective clinical therapies. Five Cores (Administrative, Clinical, Data, Biomarker/Pathology and Outreach) and 3 Research Projects (Lysosomes, Post-Synaptic Densities and GABAergic Networks) will work together to achieve this goal. Our unifying theme is a focus on the cell biology of specific neurons, and its disruption in Alzheimer's disease triggered by abnormal forms of Amyloid-β peptide. Research Projects will focus on specific neuronal organelles and specific neuronal subtypes perturbed in disease and make use of human tissue analysis and human subject imaging to evaluate mechanistic hypotheses. The Biomarker/Pathology Core will develop novel, sensitive and high-throughput mass spectrometry assays by targeted multiple-reaction monitoring (MRM) to monitor disease mechanisms. A key emphasis will be the translational development of research findings into therapeutic benefit. To support the future strength of Alzheimer's research, the Yale ADRC will strive to advance the careers of Young Investigators through mentorship from a distinguished Internal Advisory Committee, and through Pilot Project awards. In addition to collecting clinical data and biospecimens of brain, CSF, DNA, serum, blood cells and iPSCs for analysis by members of the ADRC research team, the ADRC will support other Yale NIH-funded research studies on related topics and contribute materials to national NIA-sponsored research networks. The Outreach Core will connect with the community to provide greater knowledge regarding Alzheimer's disease and related dementia.
描述(由适用提供):耶鲁ADRC试图以将实验室发现转化为新型有效临床疗法的目标,以提高我们对阿尔茨海默氏病的理解。五个核心(行政,临床,数据,生物标志物/病理和外展)和3个研究项目(溶酶体,突触后密度和GABA能网络)将共同实现这一目标。我们的统一主题是针对特定神经元的细胞生物学,以及它在异常形式的淀粉样蛋白β肽引发的阿尔茨海默氏病的破坏。研究项目将重点关注特定的神经元细胞器和疾病受干扰的特定神经元亚型,并利用人体组织分析和人类受试者成像来评估机械假设。生物标志物/病理核心将通过靶向的多反应监测(MRM)来监测疾病机制,从而开发新颖,敏感和高通量质谱法案。关键重点是将研究结果转化为治疗益处。为了支持阿尔茨海默氏症研究的未来实力,耶鲁ADRC将努力通过杰出的内部咨询委员会的心态和试点项目奖。除了收集大脑,CSF,DNA,血清,血清,血细胞和IPSC的临床数据以及ADRC研究团队成员分析外,ADRC还将支持其他耶鲁大学NIH资助的有关相关主题的研究,并为国家NIA赞助的国家NIA赞助的研究网络贡献材料。外展核心将与社区联系,以提供有关阿尔茨海默氏病和相关痴呆症的更多知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN M STRITTMATTER其他文献
STEPHEN M STRITTMATTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN M STRITTMATTER', 18)}}的其他基金
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP
阿尔茨海默病和 FTLD-TDP 中内溶酶体功能的重叠分子失调
- 批准号:
10221595 - 财政年份:2019
- 资助金额:
$ 166.5万 - 项目类别:
Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP
阿尔茨海默病和 FTLD-TDP 中内溶酶体功能的重叠分子失调
- 批准号:
10434043 - 财政年份:2019
- 资助金额:
$ 166.5万 - 项目类别:
相似海外基金
Racial/Ethnic Disparities in Health Care and Challenges in Insurance Plan Choices among Older People with Alzheimer’s Disease and Related Dementia: A Mixed Methods Study of Medicare Options
患有阿尔茨海默病和相关痴呆症的老年人在医疗保健方面的种族/民族差异以及保险计划选择的挑战:医疗保险选项的混合方法研究
- 批准号:
10723148 - 财政年份:2023
- 资助金额:
$ 166.5万 - 项目类别:
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
ACTS(AD 临床试验模拟):为阿尔茨海默病临床试验模拟系统开发先进的信息学方法
- 批准号:
10753675 - 财政年份:2023
- 资助金额:
$ 166.5万 - 项目类别: